$NUVB News

HC Wainwright & Co. Maintains Buy on Nuvation Bio, Raises Price Target to $21

Wedbush Reiterates Outperform on Nuvation Bio, Maintains $11 Price Target

Why Is Nuvation Bio Stock Gaining Monday?

Nuvation Bio Announces Positive Updated Phase 2 Data And Expansion From Safusidenib Clinical Trial In Newly-Diagnosed Grade 2 Glioma Patients Outside The U.S.

RBC Capital Cuts PT on Nuvation Bio (NUVB) in Q2 Preview

Can Nuvation Bio Inc (NUVB) Stock Soar 150% From Current Level?

RBC Capital Maintains Outperform on Nuvation Bio, Lowers Price Target to $19

Truist Securities Maintains Buy on Nuvation Bio, Raises Price Target to $13

Nuvation Bio Inc. Announces Full Exercise of Greenshoe Option in $287.5 Million Convertible Senior Notes Offering

Is Nuvation Bio’s (NUVB) Expanding Taletrectinib Footprint Quietly Rewriting Its Global Oncology Narrative?

Nuvation Bio Stock Is Up 190% Despite Recent Pressure. Should Investors Care About This $753,000 Insider Sale?

Nuvation Bio Announces Marketing Authorisation Application for Taletrectinib for the Treatment of Advanced ROS1-Positive Non-Small Cell Lung Cancer Validated in the United Kingdom

Nuvation Bio Prices $250 Million Convertible Bond Offering

Nuvation Bio Announces Pricing of Upsized Offering of $250.0 million of Convertible Senior Notes

Why Is NUVB Stock Falling Today?

Nuvation Bio Announces Proposed Convertible Senior Notes Offering

Nuvation Bio Intends To Offer $200M Aggregate Principal Amount Of Convertible Senior Notes Due In 2032

Veteran Pharma VC Insider Buys 25,000 Nuvation Bio Shares as New Drug Gains Momentum

Here’s What the Acquisition of Nuvalent Means for Nuvation Bio (NUVB)

Nuvation Bio: David Hung's Latest Venture Looks Undervalued At Current Level